Aoyi Technology Unveils Next-Decade Strategy: Building a Global Leading Brain-Computer Interface Platform from Non-Invasive Foundations

Source: Shanghai Securities News · China Securities Network

Shanghai Securities News China Securities Network (Reporter Song Weiping) On May 28, at the strategic signing ceremony between OYMotion and Minimally Invasive Brain Science, Zhang Dongdong, Director of the Brain Science Division at OYMotion, systematically outlined the company’s strategic positioning and implementation path for the next decade. He stated that over the past ten years, OYMotion has started with peripheral nerve interfaces and has built up embodied intelligenceRobot, a tripartite R&D system integrating non-invasive neural interfaces and artificial intelligence. Looking ahead to the next decade, the company aims to build a globally leading brain-computer interface platform, starting with non-invasive brain-computer interfaces.

Zhang Dongdong elaborated on this strategy from three perspectives. First, the integration of multimodal technologies accelerates the commercial implementation of the brain-computer interface (BCI) industry. He explained that single signal sources each have their limitations, whereas the fusion of multi-source physiological signals enables complementary advantages, significantly enhancing system robustness and practicality. Taking the fusion of electroencephalography (EEG) and electromyography (EMG) as an example, EEG reflects “intent,” while EMG reflects “execution.” Combining the two allows for the capture of both the user’s motor intent and the residual execution signals from muscles, substantially improving the accuracy and response speed of command recognition. Furthermore, the integration of invasive and non-invasive approaches combines the high precision of invasive electrodes with the safety and convenience of non-invasive devices. In this hybrid architecture, implanted electrodes acquire fine-grained signals from core regions, while peripheral modalities such as EEG, eye tracking, and voice provide contextual information. This “high-precision + broad-coverage” framework ensures decoding quality while reducing reliance on surgical procedures.

According to reports, OYMotion has already made strategic deployments in both of these integration pathways. Zhang Dongdong stated, “The fusion of electroencephalography (EEG) and electromyography (EMG) is precisely what our ‘Brain-Muscle-Machine’ neurorehabilitation system is designed to achieve. The company pioneered this concept, which integrates EEG, EMG, and mechanical exoskeleton devices to facilitate patient rehabilitation.”

In the field of integrating invasive and non-invasive technologies, he further stated, “Based on this trend assessment and our strategic product roadmap, we are honored to collaborate with MicroPort in the direction of interventional brain-computer rehabilitation systems. In the future, multimodal interaction will inevitably become a crucial pathway for the practical application of the brain-computer interface industry, and it is also the key area we will focus on exploring.”

Second, expanding from a single-disease breakthrough to coverage of multiple indications. OYMotion’s current products primarily focus on motor function rehabilitation after stroke, providing corresponding clinical solutions. Furthermore, the company has been progressively advancing research into the application of neuromodulation for motor function rehabilitation in patients with spinal cord injury, building upon its expertise in the field of motor function. On this basis, OYMotion will further expand into multiple indication scenarios, including cognitive function and psychiatric disorders. By evolving from a single-point breakthrough to covering multiple indications and diseases, OYMotion is driving brain-computer interface (BCI) and neuromodulation technologies toward more profound solutions for clinical challenges.

Third, foster open industrial collaboration to build a comprehensive upstream and downstream ecosystem for brain-computer interfaces (BCIs), spanning from research and development (R&D) to application. According to reports, on the R&D front, OYMotion has developed a full series of open-source EEG acquisition systems (the OB series), covering high-, mid-, and low-channel products. These systems provide a one-stop hardware and data acquisition/playback solution for the scientific research market, thereby lowering the barriers to neuroscience research. On the application front, OYMotion is one of the few enterprises with fully independent intellectual property rights and the capacity for mass delivery of dexterous robotic hands, serving over 100 companies in the embodied intelligence and humanoid robotics sectors downstream. By empowering R&D and opening up applications, OYMotion is constructing an end-to-end chain from “brain signal reading” to “execution.”